Celgene Corp (CELG)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2018 | 12-2017 | 12-2016 | 12-2015 | 12-2014 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 4,046,000 | 2,940,000 | 1,999,000 | 1,602,000 | 1,999,900 |
| Depreciation Amortization | 635,000 | 471,000 | 505,000 | 402,000 | 369,400 |
| Income taxes - deferred | 32,000 | -1,330,000 | -344,000 | -33,000 | -272,300 |
| Accounts receivable | -178,000 | -236,000 | -222,000 | -305,000 | -166,300 |
| Other Working Capital | -235,000 | 2,171,000 | 735,000 | 244,000 | 97,100 |
| Other Operating Activity | 871,000 | 1,230,000 | 1,492,000 | 875,000 | 778,500 |
| Operating Cash Flow | $5,171,000 | $5,246,000 | $4,165,000 | $2,785,000 | $2,806,300 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -330,000 | -279,000 | -236,000 | -286,000 | -150,300 |
| Net Acquisitions | -8,648,000 | N/A | N/A | -7,695,000 | -710,000 |
| Purchase Of Investment | -924,000 | -8,573,000 | -1,413,000 | -2,162,000 | -2,728,800 |
| Sale Of Investment | 3,484,000 | 5,988,000 | 648,000 | 3,892,000 | 2,175,900 |
| Other Investing Activity | 0 | -27,000 | -1,000 | -8,000 | -24,800 |
| Investing Cash Flow | $-6,418,000 | $-2,891,000 | $-1,002,000 | $-6,259,000 | $-1,438,000 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 5,709,000 | 0 | 100,000 | 6,111,000 | 2,566,900 |
| Debt Issued | 4,452,000 | 3,468,000 | 0 | 7,913,000 | 2,470,600 |
| Debt Repayment | 0 | -1,904,000 | 0 | -514,000 | 0 |
| Common Stock Issued | N/A | N/A | 8,000 | -9,000 | 307,500 |
| Common Stock Repurchased | -6,096,000 | -3,833,000 | -2,160,000 | -3,257,000 | -2,975,100 |
| Other Financing Activity | -5,605,000 | 685,000 | 218,000 | -5,961,000 | -2,787,300 |
| Financing Cash Flow | $-1,540,000 | $-1,584,000 | $-1,834,000 | $4,283,000 | $-417,400 |
| Exchange Rate Effect | 8,000 | 72,000 | -39,000 | -51,000 | -63,700 |
| Beginning Cash Position | 7,013,000 | 6,170,000 | 4,880,000 | 4,122,000 | 3,234,400 |
| End Cash Position | 4,234,000 | 7,013,000 | 6,170,000 | 4,880,000 | 4,121,600 |
| Net Cash Flow | $-2,779,000 | $843,000 | $1,290,000 | $758,000 | $887,200 |
| Free Cash Flow | |||||
| Operating Cash Flow | 5,171,000 | 5,246,000 | 4,165,000 | 2,785,000 | 2,806,300 |
| Capital Expenditure | -330,000 | -279,000 | -236,000 | -286,000 | -150,300 |
| Free Cash Flow | 4,841,000 | 4,967,000 | 3,929,000 | 2,499,000 | 2,656,000 |